Bloomberg Audio Studios, Podcasts, radio News, The Stock Movers Report, your roundup of companies making moves in the stock market, harnessing the power of Bloomberg Data.
I want to take a look now at some of the stocks on the move today. I'm Alexis Christophers along with Isabell Lee Weer in for Paul and Scarlett on this Friday, and we are joined by Bloomberg's Tatiana Darier here in studio on a Friday. Tatiana, thanks so much for stopping in. So we're going to start with the stock we've been talking about all morning long, and that's Adobe, one of the losers.
Today, one of the biggest losers today, down seven percent. They reported largely solid earnings, but the bigger news was that CEO Narayan will resign from his position as the street increasingly questions the company's ability to thrive in this AI era. The CEO has been around for eighteen years and will remain in the position until the successor has
been appointed. But this comes as a big surprise to the market, as you guys have mentioned before, with analysts saying that it adds questions around strategic continuity, capital allocation, priorities and just the future of the stock. Even though the business has been growing and steady, there's all these fears about AI disruptions which have put pressure on the stock. Hence, perhaps this is not a total surprise, yet the market always spooked when you get news like that.
What about Peloton, I feel like this is one of the famous companies during the pandemic and now it's what's going on?
Yeah, it's lost some of it shines is then as people have hit the gyms and went back to the office. But shares are slightly down here as the market rolled over was hired by two percent earlier and that's on a story we have on the terminal today. And the company is working on some new products. They want to expand their AI drint platform, pushing into strength training insights
and also communicate with users through personally plans. They also want to prioritize treadmills over bikes and even introduce lower price versions. And they're pushing for marketing campaigns to appeal to the growing number of users on GLP one weight a lot of drugs. And of course this comes after last year they tried to unsuccessfully revive and update their hardware, but Wall Street was not impressed about that. Investors punished
the stock. The hope is now that this will go better, but the caveat these new products are now at least a year away, is what our reporting shows. So wow, don't hold your hopes too high.
Just to be patient with the peloton, all right. And then here's a company we've been talking a lot about. I was never talking about this company, and now I feel like I'm doing it, like at least a couple times a week. Hymn's and Hers.
Health exactly ticker's him AS shares are also slightly down. It's given back some of its gains, but it has had a record week, and that's because they just announced a partnership with Novo Nordisk, So that's behind the fifty
three percent rally this week. As this arrangement will now allow Hymns to sell Novo's weight loss drugs, not just the copycats, or not no longer the copycats, rather because this was a part of the deal, that they will no longer advertise those compounded versions, but they said they will still sell them if the doctor requires, and only say that the deal alleviates near term concerns obviously while
putting Hymns back on the right path. And they're hoping that this time the agreement will stick because remember from last year or earlier this year in June, they announced one and then Nova accused them of deceptive market was suing them and then resue them in the end. So all of that has come for now.
The Stock Movers Report from Bloomberg Radio. Check back with us throughout the day for the latest roundup of companies making news on Wall Street and for the latest market moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg dot com, and on Applecarplay and Android Auto with the Bloomberg Business app MHM.